Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Jun;77(11):1978–1983. doi: 10.1038/bjc.1998.328

Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer.

L Baró 1, J C Hermoso 1, M C Núñez 1, J A Jiménez-Rios 1, A Gil 1
PMCID: PMC2150320  PMID: 9667678

Abstract

We evaluated total plasma fatty acid concentrations and percentages, and the fatty acid profiles for the different plasma lipid fractions and red blood cell lipids, in 17 patients with untreated colorectal cancer and 12 age-matched controls with no malignant diseases, from the same geographical area. Cancer patients had significantly lower total plasma concentrations of saturated, monounsaturated and essential fatty acids and their polyunsaturated derivatives than healthy controls; when the values were expressed as relative percentages, cancer patients had significantly higher proportions of oleic acid and lower levels of linoleic acid than controls. With regard to lipid fractions, cancer patients had higher proportions of oleic acid in plasma phospholipids, triglycerides and cholesterol esters, and lower percentages of linoleic acid and its derivatives. On the other hand, alpha-linolenic acid was significantly lower in triglycerides from cancer patients and tended to be lower in phospholipids. Its derivatives also tended to be lower in phospholipids and triglycerides from cancer patients. Our findings suggest that colorectal cancer patients present abnormalities in plasma and red blood cell fatty acid profiles characterized by lower amounts of most saturated, monounsaturated and essential fatty acids and their polyunsaturated derivatives, especially members of the n-6 series, than their healthy age-matched counterparts. These changes are probably due to metabolic changes caused by the illness per se but not to malnutrition.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alastrué Vidal A., Sitges Serra A., Jaurrieta Más E., Sitges Creus A. Valoración de los parámetros antropométricos en nuestra población. Med Clin (Barc) 1982 May 16;78(10):407–415. [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  3. Brenner R. R. Endocrine control of fatty acid desaturation. Biochem Soc Trans. 1990 Oct;18(5):773–775. doi: 10.1042/bst0180773. [DOI] [PubMed] [Google Scholar]
  4. Bégin M. E., Ells G., Das U. N., Horrobin D. F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst. 1986 Nov;77(5):1053–1062. [PubMed] [Google Scholar]
  5. Chaudry A., McClinton S., Moffat L. E., Wahle K. W. Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease. Br J Cancer. 1991 Dec;64(6):1157–1160. doi: 10.1038/bjc.1991.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Douglas R. G., Shaw J. H. Metabolic effects of cancer. Br J Surg. 1990 Mar;77(3):246–254. doi: 10.1002/bjs.1800770305. [DOI] [PubMed] [Google Scholar]
  7. Engan T., Bjerve K. S., Hoe A. L., Krane J. Characterization of plasma lipids in patients with malignant disease by 13C nuclear magnetic resonance spectroscopy and gas liquid chromatography. Blood. 1995 Mar 1;85(5):1323–1330. [PubMed] [Google Scholar]
  8. Feingold K. R., Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 1992 Oct;41 (Suppl 2):97–101. doi: 10.2337/diab.41.2.s97. [DOI] [PubMed] [Google Scholar]
  9. Feingold K. R., Serio M. K., Adi S., Moser A. H., Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology. 1989 May;124(5):2336–2342. doi: 10.1210/endo-124-5-2336. [DOI] [PubMed] [Google Scholar]
  10. Fermor B. F., Masters J. R., Wood C. B., Miller J., Apostolov K., Habib N. A. Fatty acid composition of normal and malignant cells and cytotoxicity of stearic, oleic and sterculic acids in vitro. Eur J Cancer. 1992;28A(6-7):1143–1147. doi: 10.1016/0959-8049(92)90475-h. [DOI] [PubMed] [Google Scholar]
  11. Gallagher P., Tweedle D. E. Taste threshold and acceptability of commercial diets in cancer patients. JPEN J Parenter Enteral Nutr. 1983 Jul-Aug;7(4):361–363. doi: 10.1177/0148607183007004361. [DOI] [PubMed] [Google Scholar]
  12. Glatz J. F., Soffers A. E., Katan M. B. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr. 1989 Feb;49(2):269–276. doi: 10.1093/ajcn/49.2.269. [DOI] [PubMed] [Google Scholar]
  13. Habib N. A., Wood C. B., Apostolov K., Thompson A., Barker W., Mentha G., Coutilno J., Hershman M. Desaturation-producing factor present in the tissue, blood, and urine of cancer patients. Cancer Detect Prev. 1987;10(1-2):57–61. [PubMed] [Google Scholar]
  14. Hansell D. T., Davies J. W., Burns H. J. The relationship between resting energy expenditure and weight loss in benign and malignant disease. Ann Surg. 1986 Mar;203(3):240–245. doi: 10.1097/00000658-198603000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hendrickse C. W., Kelly R. W., Radley S., Donovan I. A., Keighley M. R., Neoptolemos J. P. Lipid peroxidation and prostaglandins in colorectal cancer. Br J Surg. 1994 Aug;81(8):1219–1223. doi: 10.1002/bjs.1800810849. [DOI] [PubMed] [Google Scholar]
  16. Kern K. A., Norton J. A. Cancer cachexia. JPEN J Parenter Enteral Nutr. 1988 May-Jun;12(3):286–298. doi: 10.1177/0148607188012003286. [DOI] [PubMed] [Google Scholar]
  17. Kinsella J. E. Lipids, membrane receptors, and enzymes: effects of dietary fatty acids. JPEN J Parenter Enteral Nutr. 1990 Sep-Oct;14(5 Suppl):200S–217S. doi: 10.1177/014860719001400511. [DOI] [PubMed] [Google Scholar]
  18. Kinsella J. E., Lokesh B., Broughton S., Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition. 1990 Jan-Feb;6(1):24–62. [PubMed] [Google Scholar]
  19. Kitada S., Hays E. F., Mead J. F., Zabin I. Lipolysis induction in adipocytes by a protein from tumor cells. J Cell Biochem. 1982;20(4):409–416. doi: 10.1002/jcb.240200410. [DOI] [PubMed] [Google Scholar]
  20. Larrick J. W., Graham D., Toy K., Lin L. S., Senyk G., Fendly B. M. Recombinant tumor necrosis factor causes activation of human granulocytes. Blood. 1987 Feb;69(2):640–644. [PubMed] [Google Scholar]
  21. Lepage G., Roy C. C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986 Jan;27(1):114–120. [PubMed] [Google Scholar]
  22. Masuno H., Yamasaki N., Okuda H. Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180. Cancer Res. 1981 Jan;41(1):284–288. [PubMed] [Google Scholar]
  23. McClinton S., Moffat L. E., Horrobin D. F., Manku M. S. Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer. 1991 Feb;63(2):314–316. doi: 10.1038/bjc.1991.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McDonagh J., Fossel E. T., Kradin R. L., Dubinett S. M., Laposata M., Hallaq Y. A. Effects of tumor necrosis factor-alpha on peroxidation of plasma lipoprotein lipids in experimental animals and patients. Blood. 1992 Dec 15;80(12):3217–3226. [PubMed] [Google Scholar]
  25. Memon R. A., Feingold K. R., Moser A. H., Doerrler W., Grunfeld C. In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis. Endocrinology. 1992 Oct;131(4):1695–1702. doi: 10.1210/endo.131.4.1396316. [DOI] [PubMed] [Google Scholar]
  26. Mosconi C., Agradi E., Gambetta A., Bozzetti F., Galli C. Decrease of polyunsaturated fatty acids and elevation of the oleic/stearic acid ratio in plasma and red blood cell lipids of malnourished cancer patients. JPEN J Parenter Enteral Nutr. 1989 Sep-Oct;13(5):501–504. doi: 10.1177/0148607189013005501. [DOI] [PubMed] [Google Scholar]
  27. Neoptolemos J. P., Husband D., Imray C., Rowley S., Lawson N. Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut. 1991 Mar;32(3):278–281. doi: 10.1136/gut.32.3.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nicholson M. L., Neoptolemos J. P., Clayton H. A., Talbot I. C., Bell P. R. Increased cell membrane arachidonic acid in experimental colorectal tumours. Gut. 1991 Apr;32(4):413–418. doi: 10.1136/gut.32.4.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rashid A., Pizer E. S., Moga M., Milgraum L. Z., Zahurak M., Pasternack G. R., Kuhajda F. P., Hamilton S. R. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol. 1997 Jan;150(1):201–208. [PMC free article] [PubMed] [Google Scholar]
  30. Reddy B. S., Burill C., Rigotty J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res. 1991 Jan 15;51(2):487–491. [PubMed] [Google Scholar]
  31. Semb H., Peterson J., Tavernier J., Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem. 1987 Jun 15;262(17):8390–8394. [PubMed] [Google Scholar]
  32. Siegel I., Liu T. L., Yaghoubzadeh E., Keskey T. S., Gleicher N. Cytotoxic effects of free fatty acids on ascites tumor cells. J Natl Cancer Inst. 1987 Feb;78(2):271–277. [PubMed] [Google Scholar]
  33. Taylor D. D., Gercel-Taylor C., Jenis L. G., Devereux D. F. Identification of a human tumor-derived lipolysis-promoting factor. Cancer Res. 1992 Feb 15;52(4):829–834. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES